These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 7092581

  • 1. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P, Whiting C, Hammett F, Glick I, Miller NE, Lewis B.
    Artery; 1982; 10(2):88-94. PubMed ID: 7092581
    [Abstract] [Full Text] [Related]

  • 2. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C, Marenah CB, Miller NE, Lewis B.
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [Abstract] [Full Text] [Related]

  • 3. Effects of probucol on lipoprotein protein kinetics.
    Nestel PJ.
    Artery; 1982 Sep; 10(2):95-8. PubMed ID: 7092582
    [Abstract] [Full Text] [Related]

  • 4. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y, Kobayashi T, Yamaguchi H, Sakane H, Ozawa H, Matsuda M, Mikami Y, Mikami Y, Nakamura H.
    Artery; 1993 Sep; 20(1):1-18. PubMed ID: 8447724
    [Abstract] [Full Text] [Related]

  • 5. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Sep; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 6. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
    Fellin R, Gasparotto A, Valerio G, Baiocchi MR, Padrini R, Lamon S, Vitale E, Baggio G, Crepaldi G.
    Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
    [Abstract] [Full Text] [Related]

  • 7. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G, Witztum J, Basich P.
    Artery; 1982 Jan; 10(2):99-104. PubMed ID: 7092583
    [Abstract] [Full Text] [Related]

  • 8. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D, Bonfiglioli D, Tirrito M, Pogliaghi I, Branchi A, Cabrini E.
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [Abstract] [Full Text] [Related]

  • 9. Treatment of severe and mild hypercholesterolaemia with probucol and neomycin.
    Miettinen TA, Toivonen I.
    Postgrad Med J; 1975 Sep; 51(8):suppl 71-5. PubMed ID: 215985
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [How do changes in the plasma concentration of HDL induced by probucol operate?].
    Med Clin (Barc); 1988 Apr 02; 90(13):556-7. PubMed ID: 3393042
    [No Abstract] [Full Text] [Related]

  • 12. Probucol in hypercholesterolemia. A double blind study.
    Riesen WF, Keller M, Mordasini R.
    Atherosclerosis; 1980 Jun 02; 36(2):201-7. PubMed ID: 7406949
    [Abstract] [Full Text] [Related]

  • 13. Ultracentrifugal study of metabolic effects of probucol: plasma lipoproteins in patients with proven coronary artery disease.
    Opplt JJ, Bahler RC.
    Artery; 1982 Jun 02; 10(2):108-30. PubMed ID: 7092579
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of probucol on the in vivo plasma clearance of human low density lipoproteins in rabbits and on the expression of lipoprotein receptors in vitro.
    Trezzi E, Roma P, Bernini F, Fumagalli R, Catapano AL.
    Atherosclerosis; 1984 Sep 02; 52(3):309-16. PubMed ID: 6093829
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Pharmacology of probucol. I].
    Donatelli L.
    Clin Ter; 1984 Mar 15; 108(5):367-88. PubMed ID: 6232074
    [No Abstract] [Full Text] [Related]

  • 19. Effect of probucol on the composition of lipoproteins and on VLDL apoprotein B turnover.
    Lock DR, Kuisk I, Gonen B, Patsch W, Schonfeld G.
    Atherosclerosis; 1983 Jun 15; 47(3):271-8. PubMed ID: 6882500
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.